No products in the cart.

Hero MCM-09 Lion_s mane vs ashwagandha
Home/ Compare/ Lion’s Mane vs Ashwagandha

Lion's Mane vs Ashwagandha: A Fungus and a Root

This pairing compares a fungus with a root. Lion’s mane is Hericium erinaceus and is characterised by beta-glucans. Ashwagandha is the root of Withania somnifera, a nightshade, characterised by withanolides. The two share no marker compound and no analytical method.

One further difference outweighs the rest. Ashwagandha has published cases of liver injury, is prohibited in food supplements in Denmark, and is advised against in pregnancy.

Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic
Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic

At a glance

Property
Lion's mane
Ashwagandha
Species
Hericium erinaceus, a fungus.
Withania somnifera, a nightshade shrub.
Part used
Fruiting body yields hericenones, mycelium erinacines.
Root; India has restricted the leaf in food.
Key measured compounds
Beta-glucans, with hericenones and erinacines by chromatography.
Withanolides, principally withaferin A.
Beta-glucan content
Calculated as total glucan minus alpha-glucan, never weighed.
Absent and unmeasurable; no fungal cell wall exists in a root.
Extraction method needed
Hot water for beta-glucans, alcohol for hericenones.
Aqueous alcohol; a 70:30 ratio gave the highest withanolide content.
Traditional use context
Known in Japan as yamabushitake, used in East Asia.
A root preparation of Ayurvedic origin in India.
Human trials
One 16-week trial in 30 adults, one 28-day trial in 41.
Five trials in 254 adults, five more in 400.
What the evidence does not show
Anything beyond 16 weeks, and no dementia endpoint.
Long-term safety; one review called adverse event data limited.
Endoca product
Lion's Mane Mushroom Gummies, 100 mg extract per serving.
Endoca does not sell ashwagandha in any form.

What these two actually are

Different kingdoms, not different brands. Lion’s mane is a shaggy white fungus fruiting on hardwood, its structure built on a chitinous cell wall, and the compound families named in the literature are hericenones from the fruiting body and erinacines from the mycelium. Ashwagandha is a farmed nightshade shrub, and the commercial part is the root, whose markers are steroidal lactones called withanolides. Placing them on a single scale is a category error, so what follows sets out what each has separately been measured for.

With lion’s mane the familiar question applies: fruiting body, or mycelium raised on a grain substrate. Grain brings starch, starch is an alpha-glucan, and alpha-glucan is counted inside any total polysaccharide figure. The Endoca Lion’s Mane Mushroom Gummies describe a water-based extract standardised to 50 percent polysaccharides, which is a polysaccharide figure rather than a beta-glucan figure.

With ashwagandha the question is whether any withanolide is present at all. When nine marketed Withania somnifera formulations were assayed by chromatography, total withanolide content varied widely between them, which is why the percentage matters more than the milligram figure beside it.

Beta-glucans, and why the number on the label may not mean what you think

MCM-09 Lion_s mane vs ashwagandha second section

The beta-glucan figure belongs to the fungus alone, and even there it is inferred rather than measured directly. Total glucan is released by sulfuric acid hydrolysis and read as glucose; alpha-glucan is quantified separately once glucoamylase has digested starch and glycogen; beta-glucan is the remainder. A mycelium-on-grain powder consequently reports a generous total glucan with very little fungal glucan underneath it.

Two accepted assays also disagree with one another. The enzymatic route counts the glucose released, while the Congo red assay responds to the intact triple helix, and reviews of mushroom glucans state plainly that two values compare only when a single method produced both of them.

Ashwagandha has no counterpart figure, because no fungal cell wall exists in a root. Its analogue is withanolide content, and the same trap reappears in another form: solvent decides yield. In method development on Withania somnifera roots, aqueous alcohol mixtures returned the highest total withanolide content, so a water-only root powder and a hydroalcoholic root extract at the same stated weight are not the same material. Neither figure crosses over between the two.

What the human evidence shows

Lion's mane
Among 30 Japanese adults aged 50 to 80 with mild cognitive impairment, 16 weeks of tablets raised cognitive scale scores at weeks 8, 12 and 16.
In that same trial, scores dropped significantly 4 weeks after the tablets stopped, and no trial has run longer than 16 weeks.
In 41 healthy adults a single 1.8 gram dose quickened Stroop performance at 60 minutes, while the 28-day stress measure reached only p equals 0.051.
Ashwagandha
Pooling 5 randomised trials in 254 adults, Hamilton Anxiety Scale scores fell by a mean difference of 5.96 points, with heterogeneity of 98 percent.
Pooling 5 trials in 400 adults, sleep measures moved by a standardised mean difference of 0.59, most at 600 mg daily or above for 8 weeks or more.
That same review recorded no significant change in quality of life and stated that data on serious adverse effects are limited.

Ashwagandha has the bigger trial count and the shakier internal agreement: heterogeneity of 98 percent in the anxiety analysis means the component trials very nearly contradicted each other. Lion’s mane rests on fewer studies, one positive only while the tablets continued.

What people get wrong

01 Lion's mane and ashwagandha are interchangeable.
They have been tested for different endpoints: lion's mane studies measured cognitive scales and reaction speed, ashwagandha studies anxiety scales and sleep parameters. No trial has set one against the other.
02 Ashwagandha must be safe, it is a traditional herb.
A scoping review to December 2025 gathered 25 published cases of ashwagandha-associated liver injury. Twenty recovered, one required a transplant and three died, all three with pre-existing cirrhosis.
03 Lion's mane is established for memory.
One trial in 30 people with mild cognitive impairment recorded higher scale scores across 16 weeks, which fell back 4 weeks after stopping. No study has measured dementia incidence.

Choosing between them

Begin with who should avoid ashwagandha outright, because the list is long: anyone pregnant or breastfeeding, anyone under 18, anyone with liver disease, a thyroid disorder or a heart condition, and anyone taking central nervous system depressants. Where any of those apply the comparison is over, and lion’s mane is the only one of the pair left standing. For lion’s mane, check whether the label states fruiting body or mycelium, and read a polysaccharide percentage as the larger of the two possible numbers unless a separate beta-glucan figure is given alongside it.

How Endoca tests for this

Endoca stocks lion’s mane and not ashwagandha, so only one of the two has a batch record here. The Lion’s Mane Mushroom Gummies carry 100 mg of organic Hericium erinaceus extract per serving across 15 servings, and the Lion’s Mane Mushroom Extract capsules hold 350 mg each. Batches are tested by a third-party laboratory with the certificate of analysis published through the lab portal. The gummy label reports polysaccharides rather than beta-glucan. Endoca has worked from its own farm, own land and own extraction since 2010.

Frequently asked questions

They are not alternatives. Lion’s mane is a fungus studied for cognitive scales and reaction speed; ashwagandha is a nightshade root studied for anxiety and sleep. No trial has compared them, and only one of the two carries a documented liver injury signal.

Denmark barred it from food supplements in 2023, following a 2020 national risk assessment which found no intake level of the root or root extracts below which consumption would be free of risk. Sweden has not prohibited it, but its food agency has required companies to show that ashwagandha products are safe.

No, it is contraindicated. Germany’s risk institute advises that anyone pregnant or breastfeeding should not take it, France’s food safety agency gives the same advice, and reports have raised the possibility of spontaneous abortion. Lion’s mane has not been studied in pregnancy either.

It is thin. A double-blind trial randomised 30 adults with mild cognitive impairment into two groups of 15; scores rose at weeks 8, 12 and 16 and then fell 4 weeks after stopping. A systematic review located five randomised trials, none running past 16 weeks.

References

01

Mori K, Inatomi S, Ouchi K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372.

02

Docherty S, Doughty FL, Smith EF. The acute and chronic effects of lion’s mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients. 2023;15(22):4842.

03

Menon A, Jalal A, Arshad Z, et al. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr. 2025;12:1641246.

04

Bjornsson HK, Bjornsson ES, Avula B, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829.

05

McIntyre D, Nguyen P, Kim Y, et al. Ashwagandha (Withania somnifera)-associated liver injury: a scoping review of clinical characteristics and safety considerations. Cureus. 2026;18(5):e109764.

06

Fatima K, Malik J, Muskan F, et al. Safety and efficacy of Withania somnifera for anxiety and insomnia: systematic review and meta-analysis. Hum Psychopharmacol. 2024;39(6):e2911.

07

Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of Ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0257843.

08

Kumar S, Singh R, Gajbhiye N, Dhanani T. Extraction optimisation for phenolic- and withanolide-rich fractions from Withania somnifera roots. J AOAC Int. 2018;101(6):1773-1780.

09

McCleary BV, Draga A. Measurement of beta-glucan in mushrooms and mycelial products. J AOAC Int. 2016;99(2):364-373.

10

Bundesinstitut fuer Risikobewertung. Ashwagandha: food supplements with potential health risks. BfR Communication 39/2024, 10 September 2024.

11

Food Standards Agency. Call for evidence on the use of ashwagandha in food supplements, closed 2 September 2024; and Regulation (EC) No 1924/2006 as retained in Great Britain law.

12

DTU National Food Institute, Technical University of Denmark. Risk assessment of ashwagandha (Withania somnifera) in food supplements, 2020; and Danish Veterinary and Food Administration measure prohibiting ashwagandha in food supplements, 2023.

13

French Agency for Food, Environmental and Occupational Health and Safety (ANSES). Opinion on the risks associated with the consumption of food supplements containing ashwagandha (Withania somnifera).

14

Vetter J. The mushroom glucans: molecules of high biological and medicinal importance. Foods. 2023;12(5):1009.

Last reviewed 1 October 2026.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.